Moderna Inc (MRNA)
Total asset turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 6,775,000 | 19,263,000 | 18,471,000 | 803,000 | 60,000 |
| Total assets | US$ in thousands | 18,426,000 | 25,858,000 | 24,669,000 | 7,337,000 | 1,589,420 |
| Total asset turnover | 0.37 | 0.74 | 0.75 | 0.11 | 0.04 |
December 31, 2023 calculation
Total asset turnover = Revenue ÷ Total assets
= $6,775,000K ÷ $18,426,000K
= 0.37
The total asset turnover ratio measures how efficiently a company is utilizing its assets to generate revenue. Moderna Inc's total asset turnover has shown fluctuations over the past five years. In 2019, the ratio was relatively low at 0.04, indicating that for every dollar of assets, the company generated $0.04 in revenue. The ratio saw a significant improvement in 2020 to 0.11, suggesting a better utilization of assets to generate revenue.
Subsequently, in 2021 and 2022, Moderna's total asset turnover remained relatively stable at 0.75 and 0.74, respectively, implying a consistent performance in asset utilization to generate revenue. However, in 2023, there was a notable decrease in the ratio to 0.37, signaling a decrease in efficiency in utilizing assets to generate revenue compared to the previous years.
Overall, Moderna's total asset turnover indicates a mixed performance over the years, with fluctuations in asset utilization efficiency. Monitoring this ratio is crucial for assessing the company's operational efficiency and ability to generate revenue from its assets.
Peer comparison
Dec 31, 2023